Alzheimer's research identifies new genomic and immune system links

Recent scientific studies are uncovering new biological dimensions of Alzheimer's disease, moving beyond traditional focuses on amyloid and tau proteins.

Researchers from the University of Pittsburgh, Carnegie Mellon, and the University of Washington have discovered that the three-dimensional organization of the genome varies in certain brain cells of Alzheimer's patients. This structural change in DNA folding affects gene activity and tissue organization, offering a new regulatory layer for potential treatments.

Parallel research highlights the role of the immune system and peripheral tissues. Studies suggest that genetic signals associated with Alzheimer's are present in the lungs, intestines, and skin, indicating that peripheral inflammation and immune processes may influence brain health. Additionally, investigations into neuroimmune dysregulation are exploring how modulating immune proteins, such as PD-1, could restore microglial functions and improve communication between microglia and neurons to combat the disease.